Related Experiment Video
Updated: Feb 12, 2026
15:18
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
18.7K
Subcorneal pustular dermatosis in the pediatric age
Márcio Martins Lobo Jardim1, Ticiana Andrade Castelo Branco Diniz1, Thaís Amaral Carneiro Cunha1
1Department of Dermatology. Hospital do Servidor Público Estadual de São Paulo - São Paulo (SP), Brazil.
Anais Brasileiros De Dermatologia
|April 12, 2018
Summary
Subcorneal pustular dermatosis, a rare skin condition, presented in a 15-year-old girl. Dapsone treatment showed a positive clinical response, highlighting its efficacy in pediatric cases.
Area of Science:
- Dermatology
- Pediatric Dermatology
- Immunodermatology
Background:
- Subcorneal pustular dermatosis (SPD) is a rare pustular eruption primarily affecting middle-aged women.
- Pediatric cases of SPD are exceptionally rare, with limited documented instances.
Observation:
- A 15-year-old female presented with a four-year history of pustular lesions on her upper limbs and trunk.
- Physical examination revealed disseminated small pustules on the trunk and proximal limbs.
Findings:
- Histopathology confirmed a subcorneal pustule, characteristic of SPD.
- Direct immunofluorescence was negative for IgA, IgM, IgG, and fibrinogen, ruling out other autoimmune blistering diseases.
- The patient achieved a good clinical response after one month of dapsone therapy.
Implications:
- This case underscores the importance of considering SPD in pediatric patients presenting with pustular eruptions.
- Successful treatment with dapsone suggests its potential as an effective therapeutic option for childhood SPD.
- Further research into pediatric subcorneal pustular dermatosis is warranted to understand its unique clinical spectrum and management.
Related Concept Videos
01:26Aging
801
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
801
01:19The Effect of Aging on Tissues
3.6K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.6K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
277
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
245
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
245
01:09Changes in the Appendicular Skeleton with Age
3.6K
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.6K